European Healthtech startup funding raised during H2 2017.
In H2 2017, 153 European Healthtech companies raised a combined €1.7B across 155 funding rounds, up 90.2% versus H2 2016. Switzerland led by capital raised, and High-Tech Gründerfonds was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Nouscom | Series B | Nov 2017 | €42M |
| Ada health | Series A | Oct 2017 | €40M |
| Nightstar | Series C | Jul 2017 |
9 exits · €112M disclosed.
| VisionSense | Acquisition | Oct 2017 | €68M |
| iSalud | Acquisition | Sep 2017 | €30M |
| Vitalsana | Acquisition | Oct 2017 | €14M |
| €39M |
| Sophia Genetics | Series D+ | Jul 2017 | €26M |
| NicOx | Other | Sep 2017 | €26M |
| Natural Cycles | Series B | Nov 2017 | €26M |
| MitrAssist | Other | Nov 2017 | €26M |
| GenSight Biologics | Other | Sep 2017 | €23M |
| Doctorlink | Other | Oct 2017 | €22M |
| Push Doctor | Series B | Aug 2017 | €22M |
| Ieso | Other | Sep 2017 | €20M |
| Eligo Bioscience | Series A | Sep 2017 | €17M |
| Sparingvision | Other | Jul 2017 | €16M |
| Bioserenity | Series A | Aug 2017 | €15M |